Status
Conditions
Treatments
About
Food is emerging as the new medicine. There has been growing evidence of the beneficial effects of foods, including nuts on human health. Modulation of both glucose and insulin are at the heart of reducing the risk of cardiovascular and other metabolic diseases. The contribution that nuts have on human health has been studied extensively and it is well established that the consumption of nuts revealed improvements in both blood glucose profile and reduced the risk of coronary heart diseases. Nuts, such as almonds, are nutrient-dense foods that are particularly rich in a-tocopherol. They are excellent sources of protein (~25% of energy) and fibre, low in saturated fatty acid content (4-6%) and high in monounsaturated fatty acids. They also contain significant amounts of essential micronutrients such as folate (B vitamin) and polyphenols. Recently, strong interests on the health effects of nuts improving metabolic syndrome and controlling diabetes has been reported. Preliminary studies have indicated that the inclusion of nuts in the diets of individuals with diabetes and/or metabolic syndrome may improve postprandial glycaemic response, and lipid metabolism in the long run.
Enrollment
Sex
Ages
Volunteers
Inclusion criteria
Exclusion criteria
People who have any major organ dysfunction (eg. cardiovascular, respiratory, hepatic, renal, gastrointestinal) that may influence taste, olfaction, appetite, digestion, metabolism, absorption or elimination of test foods, nutraceutical or drug
People who smoke
People with any genetic and/or metabolic diseases (such as diabetes, hypertension etc)
People who have medical conditions and/or taking medications known to affect glycaemia (glucocorticoids, thyroid hormones, thiazide diuretics)
People with known glucose-6-phosphate dehydrogenase deficiency (G6PD deficiency)
People who have any severe food allergy (e.g. anaphylaxis to peanuts) or any known food allergy/intolerance
People who consume fibre supplements or other supplements that is likely to interfere with study outcomes
•• People who have active Tuberculosis (TB) or currently receiving treatment for TB
People who have any known Chronic infection or known to suffer from or have previously suffered from or is a carrier of Hepatitis B Virus (HBV), Hepatitis C Virus (HCV), Human Immunodeficiency Virus (HIV)
People who is a study team member or an immediate family of any study team member. Immediate family member is defined as a spouse, parent, child, or sibling, whether biological or legally adopted.
People is enrolled in a concurrent research study judged not to be scientifically or medically compatible with the study of the CNRC.
People who have intentionally restrict food intake
People who have poor veins impeding venous access
People who have any history of severe vasovagal syncope (blackouts or near faints) following blood draws
People who partake in sports at the competitive and/or endurance levels
Primary purpose
Allocation
Interventional model
Masking
15 participants in 5 patient groups
Loading...
Data sourced from clinicaltrials.gov
Clinical trials
Research sites
Resources
Legal